Literature DB >> 18378789

Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?

Y Laoudi, J-B Paolini, A Grimfed, J Just.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18378789     DOI： 10.1183/09031936.00146707

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

1.  Amphotericin B induces epithelial voltage responses in people with cystic fibrosis.

Authors:  Rajeev S Chorghade; Bo Ram Kim; Janice L Launspach; Philip H Karp; Michael J Welsh; Martin D Burke
Journal:  J Cyst Fibros       Date:  2020-12-08       Impact factor: 5.482

2.  Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Authors:  M Proesmans; F Vermeulen; M Vreys; K De Boeck
Journal:  Int J Pediatr       Date:  2010-12-23

Review 3.  Future Directions for Clinical Respiratory Fungal Research.

Authors:  Darius Armstrong-James
Journal:  Mycopathologia       Date:  2021-09-29       Impact factor: 2.574

Review 4.  Childhood allergic bronchopulmonary aspergillosis.

Authors:  Kana Ram Jat; Pankaj C Vaidya; Joseph L Mathew; Sunil Jondhale; Meenu Singh
Journal:  Lung India       Date:  2018 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.